1. Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis

   • Matthew G. Davey
   • Eoin F. Cleere
   • Michael J. Kerin

   Review Open access 15 April 2022 Pages: 535 - 544

   

2. Standardization of the tumor-stroma ratio scoring method for breast cancer research

   • Sophie C. Hagenaars
   • Kiki M. H. Vangangelt
   • Wilma E. Mesker

   Review Open access 16 April 2022 Pages: 545 - 553

   

3. Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)

   • Charles E. Geyer Jr.
   • Hanna Bandos
   • Norman Wolmark

   Clinical trial 01 March 2022 Pages: 555 - 564

   

4. Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)

   • Charles E. Geyer Jr.
   • Hanna Bandos
   • Norman Wolmark

   Correction 04 May 2022 Pages: 565 - 565

5. Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer

   • Annelieke A. Lemij
   • Nienke A. de Glas
   • Johanneke E. A. Portielje

   Clinical trial Open access 19 April 2022 Pages: 567 - 577

   

6. Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)

   • Elizabeth O’Donnell
   • Yael Shapiro
   • Jeffrey Peppercorn

   Clinical trial 20 April 2022 Pages: 579 - 587

   

7. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy

   • Jana de Boniface
   • Jan Frisell
   • Steffi Hartmann

   Clinical trial Open access 22 April 2022 Pages: 589 - 595

   

8. Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years

   • Lisi M. Dredze
   • Michael Friger
   • David B. Geffen

   Clinical trial 22 April 2022 Pages: 597 - 612

   

9. Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases

   • Akshjot Puri
   • Charisma Mylavarapu
   • Polly Niravath

   Clinical trial 23 April 2022 Pages: 613 - 623

   

10. Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer

    • Temidayo A. Fadelu
    • Parsa Erfani
    • Timothy R. Rebbeck

    Epidemiology Open access 14 April 2022 Pages: 625 - 635

    

11. RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis

    • Dooreh Kim
    • Soong June Bae
    • Chang Ik Yoon

    Epidemiology 15 April 2022 Pages: 637 - 647

    

12. Prognostic significance of abdominal obesity and its post-diagnosis change in a Chinese breast cancer cohort

    • Gary K. K. Chung
    • Winnie Yeo
    • Suzanne C. Ho

    Epidemiology 16 April 2022 Pages: 649 - 658

13. Breast-conserving surgery with whole breast radiation therapy has a subsequent lower mood disorder incidence rate than total mastectomy in early-stage breast cancer patients: a nationwide population-based longitudinal study

    • Yen-Hsiang Liao
    • Jung-Nien Lai
    • Dai-Wei Liu

    Epidemiology 16 April 2022 Pages: 659 - 667

    

14. Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer

    • Marilyn L. Kwan
    • Richard K. Cheng
    • Jamal S. Rana

    Epidemiology 16 April 2022 Pages: 669 - 675

    

15. Association between weight change and breast cancer prognosis

    • Yi-Xin Zhang
    • Zhuo-Zhi Liang
    • Ze-Fang Ren

    Epidemiology 18 April 2022 Pages: 677 - 684

16. Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey

    • K. Vandraas
    • R. S. Falk
    • K. V. Reinertsen

    Epidemiology Open access 21 April 2022 Pages: 685 - 694

17. Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017

    • Hanxi Zhang
    • Jamie C. Barner
    • Dhatri Kodali

    Epidemiology 21 April 2022 Pages: 695 - 705

    

18. Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity

    • Hsiao-Ching Huang
    • Mary H. Smart
    • Gregory S. Calip

    Epidemiology 23 April 2022 Pages: 707 - 716